Recent Updates
Recently added Catalysts
AMGN

Amgen To Present At The Baird Healthcare Conference Amgen (NASDAQ:AMGN) will participate in the Baird Healthcare Conference on Thursday, Sept. 6, 2012, at The New York Palace Hotel in New York City,...

Key Takeaway: THOUSAND OAKS, Calif. , Aug. 31, 2012 /PRNewswire/ -- Amgen (NASDAQ: AMGN ) will participate in the Baird Healthcare Conference on Thursday, Sept. 6, 2012 , at The New York Palace Hotel in New York City , beginning at 1:24 p.m. Eastern Daylight Time . Arvind Sood , vice president

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+30%
120-day peak, hindsight
Typical move
1.4%
average across 15 past catalysts
Lead asset
Maridebart cafraglutide
Phase 3 · Heart Failure With Preserved Ejection Fraction

Full Press Release Details

THOUSAND OAKS, Calif. , Aug. 31, 2012 /PRNewswire/ -- Amgen (NASDAQ: AMGN ) will participate in the Baird Healthcare Conference on Thursday, Sept. 6, 2012 , at The New York Palace Hotel in New York City , beginning at 1:24 p.m. Eastern Daylight Time . Arvind Sood , vice president of Investor Relations at Amgen, will present. Live audio of the presentation can be accessed from the Events Calendar on Amgen's website, www.amgen.com , under Investors.
CONTACT: Amgen, Thousand Oaks Christine Regan , 805-447-5476 (media) Eric Hylengren, 805-447-1060 (investors)
Last updated: Aug 31, 2012